Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Riociguat (Adempas)
DRUG
2 trials
Sponsors
Actelion
, Chinese University of Hong Kong
Conditions
Chronic Thromboembolic Pulmonary Hypertension
Healthy Subjects
Phase 1
Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics
Completed
NCT03389321
Actelion
Healthy Subjects
Start: 2018-01-09
End: 2018-02-06
Updated: 2018-02-08
Phase 4
Switching of Sildenafil to Riociguat in CTEPH Patients
Recruiting
NCT06715280
Chinese University of Hong Kong
Chronic Thromboembolic Pulmonary Hypertension
Start: 2024-07-25
End: 2027-01-22
Target: 30
Updated: 2025-05-29
Related Papers
Haemodynamic and clinical impacts of switching phosphodiesterase-5 inhibitors to riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) - a prospective cohort study.
2026-01-03